Packaging

Translating medicine packaging information for international markets is a major challenge.

The UK Competition and Markets Authority (CMA) has handed out a £37.6 million fine to GSK for paying out “value transfers totaling over 50 million pounds” to competitors between 2001 and 2004 to delay the introduction of generic versions of its branded anti-depressant drug, Seroxat (paroxetine).

Sitting Down With... Diane Paskiet, Director of Scientific Affairs at West Pharmaceutical Services, USA.

Although the discussion about the use of preservatives is still somewhat controversial, clinical evidence suggests that patients benefit from unpreserved eye drops especially in chronic conditions.

Regulators are driving serialization and tamper-evident packaging initiatives, but is the pharma industry fully primed to defend against counterfeits?

The technology has barely changed over the last 30 years – surely, it’s time for some long overdue innovation.

Using tiny imperfections in the printing process to track individual products through the supply chain

But can pharma manufacturers do more to help prevent medication errors?

Just how prevalent is pharmacogenomic information on European drug labels?

What’s convenient for manufacturers does not always result in a product that’s best for patients.